PTX 4.08% 4.7¢ prescient therapeutics limited

Ann: December 2023 Quarterly Update and Appendix 4C, page-2

  1. 96 Posts.
    lightbulb Created with Sketch. 27
    In addition to robust efficacy, PTX-100’s safety profile was acknowledged as a distinguishing feature, which could also make it a viable option for exploring future combination therapies.

    PLUS at least 6 quarters of runway in cash. One for the patient investor who recognises the enormous potential.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.7¢
Change
-0.002(4.08%)
Mkt cap ! $37.85M
Open High Low Value Volume
4.9¢ 5.0¢ 4.6¢ $54.50K 1.134M

Buyers (Bids)

No. Vol. Price($)
2 108715 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 189091 2
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.